Preliminary phase II results of oxaliplatin, 5-FU, and leucovorin in advanced biliary tract cancer.

被引：0
作者：
Lee, S.
Kim, H.
Kim, S.
Kim, C.
Bae, S.
Lee, K.
Yun, J.
Hong, D.
Park, H.
机构：
[1] Soonchunhyang Univ Hosp, Seoul, South Korea
[2] Soonchunhyang Univ, Bucheon Hosp, Puchon, South Korea
[3] Soonchunhyang Univ, Cheonan Hosp, Cheonan, South Korea
[4] Soonchunhyang Univ Cheonan, Cheonan, South Korea
[5] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e14507
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14507
引用
收藏
页数：1
相关论文
共 50 条
[31]   Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin (PLF) in locally advanced gastric cancer: a prospective phase II study [J].
Katja Ott ;
Andreas Sendler ;
Karen Becker ;
Hans-Joachim Dittler ;
Hermann Helmberger ;
Raimonde Busch ;
Christian Kollmannsberger ;
J. Rüdiger Siewert ;
Ulrich Fink .
Gastric Cancer, 2003, 6 (3) :159-167
[32]   Final results of first line treatment with 5-fluorouracil (5-FU), leucovorin (LV) and oxaliplatin (L-OHP) in advanced colorectal cancer (ACC): A multicenter phase II study. [J].
Souglakos, J ;
Kouroussis, C ;
Ziras, N ;
Malamos, N ;
Potamianou, A ;
Mavroudis, D ;
Kakolyris, S ;
Androulakis, N ;
Vardakis, N ;
Georgoulias, V .
ANNALS OF ONCOLOGY, 2000, 11 :49-49
[33]   EXIBIT:: An international multicenter phase II trial of gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer. [J].
André, T. ;
Reyes-Vidal, J. M. ;
Fartoux, L. ;
Ross, P. ;
Leslie, M. ;
Rosmorduc, O. ;
Clemens, M. R. ;
Louvet, C. ;
Perez, N. ;
Scheithauer, W. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) :211S-211S
[34]   Multicenter phase II study of docetaxel and oxaliplatin combination in patients with locally advanced or metastatic biliary tract cancer. [J].
Song, Eun-Kee ;
Han, Hye-Suk ;
Lee, Ki Hyeong ;
Lee, Kyu Taek ;
Bae, Sang Byung ;
Kim, Han Jo ;
Kim, Samyong ;
Yun, Hwan Jung ;
Cho, Sang Hoe ;
Shim, Hyun-Jeong ;
Yhim, Ho-Young ;
Leo, Na-Ri ;
Joon, So Yoon ;
Yim, Chang-Yeoi .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[35]   A Multicenter Phase-II Study of 5-FU, Leucovorin and Oxaliplatin (FOLFOX6) in Patients with Pretreated Metastatic Colorectal Cancer [J].
Kato, Ken ;
Inaba, Yoshitaka ;
Tsuji, Yasushi ;
Esaki, Taito ;
Yoshioka, Akira ;
Mizunuma, Nobuyuki ;
Mizuno, Toshiro ;
Kusaba, Hitoshi ;
Fujii, Hirohumi ;
Muro, Kei ;
Shimada, Yasuhiro ;
Shirao, Kuniaki .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (01) :63-68
[36]   Phase Ib study of gemcitabine and oxaliplatin with erlotinib in patients with advanced biliary tract cancer. [J].
Ciombor, Kristen Keon ;
Cardin, Dana Backlund ;
Chan, Emily ;
McClanahan, Pamela ;
Fan, Kang-Hsien ;
Flynn, Jayme ;
Young, Ruth T. ;
DeMers, April ;
Smith, Stephen James ;
Berlin, Jordan ;
Goff, Laura Williams .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[37]   Oxaliplatin added to simplified bimonthly low-dose leucovorin and 5-FU for pretreated advanced colorectal cancer is effective and not affected by different previous 5-FU regimens [J].
Hsieh, RK ;
Chao, TY ;
Chen, WS ;
Yang, TS ;
Chen, LT ;
Chen, PM ;
Liu, JH .
CANCER INVESTIGATION, 2004, 22 (02) :171-179
[38]   Oxaliplatin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in previously treated patients with advanced metastatic gastric cancer [J].
Cavanna, L ;
Zaniboni, A ;
Artioli, F ;
Lazzaro, A ;
Rizzi, A ;
Mazzocchi, M ;
Anselmi, E ;
Bidin, L ;
Palladino, M ;
Rodinò, C .
ANNALS OF ONCOLOGY, 2005, 16 :323-323
[39]   Randomized phase II study of combined infusional leucovorin sodium (LVNa) and 5-FU versus the sequential administration of leucovorin calcium (LVCa) followed by 5-FU with irinotecan or oxaliplatin in patients (pts) with metastatic colorectal cancer (mCRC) [J].
Bleiberg, H. ;
Vandebroek, A. ;
Deleu, I. ;
Vergauwe, P. ;
Kalantari, H. Rezael ;
D'Haens, G. ;
Paesmans, M. ;
Peeters, M. ;
Efira, A. ;
Humblet, Y. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[40]   UFT/leucovorin vs 5-FU/leucovorin in colon cancer [J].
Smith, RE ;
Lembersky, BC ;
Wieand, HS ;
Colangelo, L ;
Mamounas, EP .
ONCOLOGY-NEW YORK, 2000, 14 (10) :24-27
12345